Improved quality of life in head and neck cancer patients treated with modern arc radiotherapy techniques - A prospective longitudinal analysis
- PMID: 39376987
- PMCID: PMC11456567
- DOI: 10.3389/fonc.2024.1424034
Improved quality of life in head and neck cancer patients treated with modern arc radiotherapy techniques - A prospective longitudinal analysis
Abstract
Purpose: The present longitudinal study aimed to evaluate the potential impact of modern radiotherapy (RT) techniques on quality of life (QOL) in patients with head and neck (HNC) cancer.
Materials and methods: In this single-center prospective study, participants were asked to complete QOL questionnaires that included the EORTC QLQ-C30, QLQ-H&N 35 and utility score by time trade-off (TTO) at three time points (2 weeks, 3 months and 6 months) after completion of RT. All patients were treated by modern RT techniques [volumetric modulated arc therapy (VMAT) or helical tomotherapy (HT)]. Patients who developed recurrence or died before the 6-month follow-up were excluded. Linear mixed models with random intercepts for participants and restricted maximum likelihood estimates were used to assess the effect of our study variables (age, sex, primary site, cancer stage, treatment, radiation dose and radiation method). Overall changes in QOL, utility scores and symptom burdens at different time points were tested using paired t tests.
Results: A total of 45 patients were recruited from 2022 to 2023. Those who completed the surveys at 2 weeks with at least 1 follow-up (30 patients, 67%) were enrolled in the final analysis. The majority of these 30 patients were men (76.7%), had oral cancer (40%), had stage III or IV disease (60%), received surgical intervention (63%) and were treated with chemoradiation (80%). A curative total dose of 66 to 70 Gy was delivered to 23 (76.7%) patients, half of whom received HT. Patients who received chemotherapy had significantly lower global QoL scales (mean difference, 27.94; 95% CI, 9.33-46.55; p=0.005). Global QOL, physical function, symptoms of sticky saliva, cough, feelings of illness and weight loss improved significantly between 2 weeks and 3 months. There was no significant difference between 3 and 6 months. Interestingly, improvements in social function, social contact, pain and nutrition reached significance at 6 months. Subgroup analysis revealed greater pain relief over time for patients who underwent HT (p=0.030). Moreover, patients who participated in swallowing rehabilitation programs had a greater decrease in nausea and vomiting (p=0.036).
Conclusion: HNC patients treated with modern RT techniques experience improved QOL and physical function over time. The most significant improvement occurs between 2 weeks and 3 months, after which the improvement plateaus. However, social function, social contact, pain and nutrition may require longer recovery intervals after treatment. HT with daily image guidance could provide a therapeutic opportunity for improving pain relief in patients with HNC.
Keywords: VMAT (volumetric modulated arc therapy); arc radiation therapy; head and neck cancer; quality of life; radiation therapy (radiotherapy); tomotherapy.
Copyright © 2024 Chuang, Hou, Shueng, Lo, Lin, Lin, Wu, Jiang, Chung, Hsu, Kuo, Lu, Liao and Hsieh.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.BMC Cancer. 2011 Apr 12;11:128. doi: 10.1186/1471-2407-11-128. BMC Cancer. 2011. PMID: 21486431 Free PMC article.
-
Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.Radiat Oncol. 2020 Apr 19;15(1):84. doi: 10.1186/s13014-020-01532-4. Radiat Oncol. 2020. PMID: 32307024 Free PMC article.
-
Quality of Life: A Prospective Randomized Trial of Palliative Volumetric Arc Therapy Versus 3-Dimensional Conventional Radiation Therapy.Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1431-1439. doi: 10.1016/j.ijrobp.2020.11.061. Epub 2020 Nov 28. Int J Radiat Oncol Biol Phys. 2021. PMID: 33259935 Clinical Trial.
-
Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.Expert Rev Anticancer Ther. 2015 Jan;15(1):109-19. doi: 10.1586/14737140.2015.961427. Epub 2014 Sep 18. Expert Rev Anticancer Ther. 2015. PMID: 25231774 Review.
-
Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era - A systematic review.Clin Transl Radiat Oncol. 2024 Aug 28;49:100845. doi: 10.1016/j.ctro.2024.100845. eCollection 2024 Nov. Clin Transl Radiat Oncol. 2024. PMID: 39290455 Free PMC article. Review.
References
-
- Hsieh C-H, Shueng P-W, Wang L-Y, Huang Y-C, Liao L-J, Lo W-C, et al. . Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer. BMC Cancer. (2016) 16:139. doi: 10.1186/s12885-016-2165-9 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources